Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine
- PMID: 9613364
- PMCID: PMC1717498
- DOI: 10.1136/adc.78.3.273
Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine
Abstract
Three cases of immune thrombocytopenic purpura after the first dose of recombinant hepatitis B vaccine occurred in infants under 6 months of age. Other possible causes of this condition were excluded. Antiplatelet antibodies were present. A defect in platelet production was excluded in two children. Corticosteroid treatment was effective. Subsequent administration of other vaccines (against polio, diphtheria, and tetanus) did not cause relapse of thrombocytopenia.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources